Literature DB >> 17687397

Involvement of MAPK/ERK kinase-ERK pathway in exogenous bFGF-induced Egr-1 binding activity enhancement in anoxia-reoxygenation injured astrocytes.

Ying Liu1, Jin-Biao Lu, Qi Chen, Zhu-Rong Ye.   

Abstract

OBJECTIVE: Intravenous administration of basic fibroblast growth factor (bFGF) is effective to reduce the volume of cerebral infract due to ischemia. This study was designed to investigate the molecular mechanism, especially the signal transduction pathways, involved in this protective role of bFGF.
METHODS: Anoxia-reoxygenation treated astrocytes were used to study the role of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MAPK/ERK kinase, MEK)-ERK signaling pathway after exogenous bFGF administration by Western blot. Electrophoretic mobile shift assay was used to detect the binding activity of early growth response factor-1 (Egr-1), an important transcription factor for endogenous bFGF.
RESULTS: bFGF could protect some signal transduction proteins from the oxygen-derived free radicals induced degradation. ERK1/2 was activated and involved in Egr-1 binding activity enhancement induced by exogenous bFGF.
CONCLUSION: MEK-ERK MAPK cascade may be an important signal transduction pathway contributed to bFGF induced enhancement of Egr-1 binding activity in anoxia-reoxygenation injured astrocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17687397      PMCID: PMC5550585          DOI: 10.1007/s12264-007-0033-y

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  23 in total

1.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

2.  Positive regulation of Raf1-MEK1/2-ERK1/2 signaling by protein serine/threonine phosphatase 2A holoenzymes.

Authors:  Deanna G Adams; R Lane Coffee; Hong Zhang; Steven Pelech; Stefan Strack; Brian E Wadzinski
Journal:  J Biol Chem       Date:  2005-10-20       Impact factor: 5.157

3.  Permeability of injured blood brain barrier for exogenous bFGF and protection mechanism of bFGF in rat brain ischemia.

Authors:  Ying Liu; Jin-Biao Lu; Zhu-Rong Ye
Journal:  Neuropathology       Date:  2006-06       Impact factor: 1.906

4.  Basic fibroblast growth factor enhances axonal sprouting after cortical injury in rats.

Authors:  J J Ramirez; S P Finklestein; J Keller; W Abrams; M N George; T Parakh
Journal:  Neuroreport       Date:  1999-04-26       Impact factor: 1.837

5.  Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.

Authors:  Qiu Li; Diane Stephenson
Journal:  Exp Neurol       Date:  2002-10       Impact factor: 5.330

6.  Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus.

Authors:  M U Ehrengruber; S G Muhlebach; S Söhrman; C M Leutenegger; H A Lester; N Davidson
Journal:  Gene       Date:  2000-11-27       Impact factor: 3.688

7.  Egr-1 activates basic fibroblast growth factor transcription. Mechanistic implications for astrocyte proliferation.

Authors:  E Biesiada; M Razandi; E R Levin
Journal:  J Biol Chem       Date:  1996-08-02       Impact factor: 5.157

8.  Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis, and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose.

Authors:  M P Mattson; Y Zhang; S Bose
Journal:  Exp Neurol       Date:  1993-05       Impact factor: 5.330

9.  Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.

Authors:  Irina Kiprianova; Katharina Schindowski; Oliver von Bohlen und Halbach; Sonja Krause; Rosanna Dono; Markus Schwaninger; Klaus Unsicker
Journal:  Exp Neurol       Date:  2004-10       Impact factor: 5.330

Review 10.  Endogenous neuroprotection factors and traumatic brain injury: mechanisms of action and implications for therapy.

Authors:  M P Mattson; S W Scheff
Journal:  J Neurotrauma       Date:  1994-02       Impact factor: 5.269

View more
  2 in total

1.  Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways.

Authors:  Jing-Jun Sun; Ying Liu; Zhu-Rong Ye
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

2.  Thermosensitive heparin-poloxamer hydrogel encapsulated bFGF and NGF to treat spinal cord injury.

Authors:  Xiaoli Hu; Rui Li; Yanqing Wu; Yi Li; Xingfeng Zhong; Guanyinsheng Zhang; Yanmin Kang; Shuhua Liu; Ling Xie; Junming Ye; Jian Xiao
Journal:  J Cell Mol Med       Date:  2020-06-08       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.